Cell-Penetrating Peptide Conjugated to Methylene Blue Enhances Cancer Photodynamic Therapy
Conjugating methylene blue to a cell-penetrating peptide (protamine) improved cellular uptake and lysosome targeting, enhancing photodynamic therapy efficacy against cancer cells.
Quick Facts
What This Study Found
CPP-methylene blue conjugates showed enhanced cellular uptake, lysosomal localization, and improved photodynamic therapy efficacy against cancer cells compared to unconjugated methylene blue.
Key Numbers
MB-Pro localized to lysosomes; induced necrosis vs apoptosis with MB alone
How They Did This
Conjugated protamine CPP with methylene blue via chemical coupling, purified by FPLC. Tested cellular uptake, subcellular localization, and PDT efficacy in cancer cell lines in vitro.
Why This Research Matters
Photodynamic therapy is limited by poor photosensitizer uptake into cancer cells. CPP conjugation could overcome this barrier, making PDT a more effective cancer treatment option.
The Bigger Picture
This work demonstrates the versatility of cell-penetrating peptides as delivery vehicles beyond traditional drugs — here carrying a photosensitizer to enable light-activated cancer treatment.
What This Study Doesn't Tell Us
In vitro study only — no in vivo tumor PDT data. Light penetration limits PDT to superficial or accessible tumors. Selectivity for cancer over normal cells not fully characterized.
Questions This Raises
- ?Would CPP-MB conjugates show selective tumor accumulation in vivo?
- ?Can this approach be combined with checkpoint immunotherapy for enhanced anti-tumor effects?
- ?How does the PDT efficacy compare to established photosensitizers used clinically?
Trust & Context
- Key Stat:
- Enhanced PDT with CPP delivery Protamine CPP conjugation improved methylene blue uptake and lysosome targeting for more effective cancer photodynamic therapy
- Evidence Grade:
- Preliminary — in vitro proof of concept demonstrating enhanced PDT with CPP delivery; no animal or clinical data.
- Study Age:
- Published in 2020; CPP-photosensitizer conjugates remain an active area of cancer PDT research.
- Original Title:
- Enhanced Efficacy of Photodynamic Therapy by Coupling a Cell-Penetrating Peptide with Methylene Blue.
- Published In:
- International journal of nanomedicine, 15, 5803-5811 (2020)
- Authors:
- Ser, Jinhui, Lee, Ji Yeon(2), Kim, Yong Ho(2), Cho, Hoonsung
- Database ID:
- RPEP-05120
Evidence Hierarchy
Frequently Asked Questions
What is photodynamic therapy?
PDT uses a light-sensitive drug (photosensitizer) that accumulates in cancer cells. When activated by specific wavelength light, it produces reactive oxygen species that kill the cancer cells while sparing unirradiated tissue.
Why attach a cell-penetrating peptide to the photosensitizer?
Photosensitizers like methylene blue often cannot efficiently enter cancer cells on their own. The CPP acts as a delivery vehicle, carrying the photosensitizer inside cells and directing it to lysosomes, where PDT-generated damage is most lethal.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05120APA
Ser, Jinhui; Lee, Ji Yeon; Kim, Yong Ho; Cho, Hoonsung. (2020). Enhanced Efficacy of Photodynamic Therapy by Coupling a Cell-Penetrating Peptide with Methylene Blue.. International journal of nanomedicine, 15, 5803-5811. https://doi.org/10.2147/IJN.S254881
MLA
Ser, Jinhui, et al. "Enhanced Efficacy of Photodynamic Therapy by Coupling a Cell-Penetrating Peptide with Methylene Blue.." International journal of nanomedicine, 2020. https://doi.org/10.2147/IJN.S254881
RethinkPeptides
RethinkPeptides Research Database. "Enhanced Efficacy of Photodynamic Therapy by Coupling a Cell..." RPEP-05120. Retrieved from https://rethinkpeptides.com/research/ser-2020-enhanced-efficacy-of-photodynamic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.